Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-15

Clinical Trial Update: Prospective National Cohort Evaluating Prognostic Factors for Efficacy of Fruquintinib Treatment in Patients With Metastatic Colorectal Cancer [NA]

View source ↗

Summary

Clinical trial registry entry for a national cohort study evaluating prognostic factors for the efficacy of Fruquintinib in patients with metastatic colorectal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fruquintinib (fruquintinib)

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Metastatic Colorectal Cancer (CRC), Antineoplastic Agents, Immunological | NA | Status: NOT_YET_RECRUITING